Mackay Shields LLC’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-15,624
Closed -$3.54M 500
2022
Q1
$3.54M Sell
15,624
-1,062
-6% -$250K 0.03% 432
2021
Q4
$4.5M Sell
16,686
-732
-4% -$181K 0.04% 398
2021
Q3
$4.21M Sell
17,418
-503
-3% -$127K 0.04% 378
2021
Q2
$4.25M Sell
17,921
-30,248
-63% -$6.89M 0.04% 373
2021
Q1
$10.6M Sell
48,169
-9,150
-16% -$1.84M 0.08% 270
2020
Q4
$10M Buy
57,319
+34,619
+153% +$5.98M 0.07% 307
2020
Q3
$3.67M Sell
22,700
-31,533
-58% -$5M 0.02% 527
2020
Q2
$7.74M Buy
54,233
+36,742
+210% +$5.08M 0.06% 334
2020
Q1
$1.9M Sell
17,491
-90
-0.5% -$13K 0.02% 690
2019
Q4
$2.56M Sell
17,581
-1,193
-6% -$172K 0.02% 770
2019
Q3
$2.71M Buy
18,774
+1,611
+9% +$235K 0.02% 770
2019
Q2
$2.55M Buy
17,163
+222
+1% +$31K 0.02% 805
2019
Q1
$2.23M Sell
16,941
-1,468
-8% -$181K 0.02% 664
2018
Q4
$2M Sell
18,409
-508
-3% -$68.1K 0.02% 670
2018
Q3
$2.82M Sell
18,917
-357
-2% -$54.3K 0.02% 614
2018
Q2
$2.97M Sell
19,274
-673
-3% -$102K 0.02% 653
2018
Q1
$2.77M Buy
+19,947
New +$2.93M 0.02% 689

Other funds holding LH

Mackay Shields LLC's LH Position: Q2 2022 in Review

Mackay Shields LLC sold out of Labcorp (LH) in Q2 2022, closing a stake of 15,624 shares — an estimated $3.54M sold.

Mackay Shields LLC first reported a position in LH in Q1 2018 and held it in 17 quarters. The position peaked at $10.6M in Q1 2021. 966 funds tracked by Wall St. Rank hold LH as of Q2 2022.

  • Mackay Shields LLC reported no remaining Labcorp position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 15,624 Labcorp shares in Q2 2022, an estimated $3.54M.
  • Mackay Shields LLC first reported a position in Labcorp in Q1 2018 and held it in 17 quarters.
  • Mackay Shields LLC's Labcorp position peaked at $10.6M in Q1 2021.
  • 966 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.